Clinical analysis of the treatment of spinocerebellar ataxia and multiple system atrophy-cerebellar type with umbilical cord mesenchymal stromal cells

Cytotherapy

Volumn 13, Issue 8, 2011, Pages 913-917

  Dongmei, Han ^a   Jing, Liu ^a   Mei, Xue ^a   Ling, Zhu ^a   Hongmin, Yan ^a   Zhidong, Wang ^a   Li, Ding ^a   Zikuan, Guo ^b   Hengxiang, Wang ^a  

^a AIR FORCE GENERAL HOSPITAL   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

mesenchymal stromal cells; multiple system atrophy; spinocerebellar ataxia; umbilical cord

Indexed keywords

ADULT; ARTICLE; BACKACHE; CELL THERAPY; CLINICAL ARTICLE; DISEASE COURSE; DIZZINESS; DYSARTHRIA; FEMALE; FOLLOW UP; HEADACHE; HUMAN; MALE; MESENCHYME CELL; MOTOR DYSFUNCTION; MULTIPLE SYSTEM ATROPHY CEREBELLAR TYPE; PRIORITY JOURNAL; QUALITY OF LIFE; SHY DRAGER SYNDROME; SPINOCEREBELLAR DEGENERATION; STANDING; TREATMENT OUTCOME; UMBILICAL CORD; WALKING;

EID: 80051903686     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2011.579958     Document Type: Article

References (18)

1. Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol. 2004;3:93-103. (Pubitemid 38121312)
2. Avanzini MA, Bernardo ME, Cometa AM, Perotti C, Zaffaroni N, Novara F, et al. Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors. Haematologica. 2009; 94:1649-60.
3. Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol. 2004;36:568-84. (Pubitemid 38324589)
4. Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999;163:94-8. (Pubitemid 29155424)
5. Huang HY. Prosthetics of central nervous system. Peking Science Publishing Co. Peking. 2009;4:479-82.
6. Lawton and Brody. Activity of daily living scale (ADL). Chinese J Min Inv Neurosurg. 2006;11:516-516.
7. Alison MR, Poulsom R, Forbes S, Wright NA. An introduction of stem cells. J Path. 2002;197:419-23.
8. Cho PS, Messina DJ, Hirsh EL, Chi N, Goldman SN, Lo DP, et al. Immunogenicity of umbilical cord tissue derived cells. Blood. 2008;111:430-8.
9. Satake K, Lou J, Lenke LG. Migration of mesenchymal stem cells through cerebrospinal fl uid into injured spinal cord tissue. Spine Phila Pa. 1976. 2004;29:1971 - 9. (Pubitemid 40202267)
10. Meirelles LS, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119:2204-13. (Pubitemid 43960310)
11. Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson ' s disease. Stem Cells. 2006;24:781-92. (Pubitemid 44464783)
12. Lee PH, Kim JW, Bang OY, Ahn YH, Joo IS, Huh K. Autologous mesenchymal stem cell therapy delays the progression of neurological defi cits in patients with multiple system atrophy. Clin Pharmamacol Ther. 2008;83:723-30. (Pubitemid 351556019)
13. Burns JS, Abdallah BM, Schrøder HD, Kassem M. The histopathology of a human mesenchymal stem cell experimental tumor model: support for an hMSC origin for Ewing ' s sarcoma? Histol Histopathol. 2008;23:1229-40.
14. R ubio D, Garcia S, Paz MF, De la Cueva T, Lopez-Fernandez LA, Lloyd AC, et al. Molecular characterization of spontaneous mesenchymal stem cell transformation. PloS One. 2003;3:e1398 - 1398.
15. Ding DC, Shyu WC, Chiang MF, Lin SZ, Chang YC, Wang HJ, et al. Enhancement of neuroplasticity through upregulation of betal-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiol Dis. 2007; 27:339-53.
16. Koh SH, Kim KS, Choi MR, Jung KH, Park KS, Chai YG, et al. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res. 2008; 1229:223-48.
17. Kan I, Melamed E, Offen D. Autotransplantation of bone marrow-derived stem cells as a therapy for neurodegenerative diseases. Hand Exp Pharmacol. 2007;180:219-42.
18. Lee PH, Park HJ. Bone marrow-derived mesenchymal stem cell therapy as a candidate disease-modifying strategy in Parkinson ' s disease and multiple system atrophy. J Clin Neurol. 2009;5:1-10.